Dr. Rosenthal obtained her Ph.D. from Harvard Medical School, trained as a postdoctoral fellow at the National Institutes of Health, directed a biomedical research laboratory at Harvard Medical School, and served for a decade at the New England Journal of Medicine as editor of the Molecular Medicine series. In 2001, she moved to Rome to head the European Molecular Biology Laboratory (EMBL) Mouse Biology Unit, and holds a Professorship of Cardiovascular Science at Imperial College London. She is an European Molecular Biology Organization member, with numerous awards and honors including the Ferrari-Soave Prize in Cell Biology and Doctors Honoris Causa from the Pierre and Marie Curie University in Paris and the University of Amsterdam. She spearheaded the election of Australia to EMBL as its first associate member, and in 2008 she founded the Australian Regenerative Medicine Institute at Monash University that serves as headquarters for the EMBL Australia Partner Laboratory Network. She is an National Health and Medical Research Council Australia Fellow.
Dr. Rosenthal’s research focuses on muscle and cardiac developmental genetics and the role of growth factors and stem cells in tissue regeneration, with over 160 primary research articles and prominent reviews in high-impact international journals, including general reviews on stem cells in biology and medicine for Scientific American. She delivered the 2006 Howard Hughes Holiday Lectures on Potent Biology: Stem Cells, Cloning and Regeneration. She has attracted sponsored research funding from major pharmaceutical companies including Amgen, Genzyme, and Novartis for her translational studies in stem cell and regenerative medicine. She brings a unique and powerful perspective on stem cell biology at the interface of basic, biomedical, and industrial life sciences.